Preview

PDF Licofelone.pdf | Download (68kB) Available under University of Tasmania Standard License. | Preview

Abstract

EuroAlliance (a consortium of Alfa Wassermann SpA, Lacer SA
and Merckle GmbH) is developing licofelone, a dual
cyclooxygenase and 5-lipoxygenase inhibitor for the potential
treatment of inflammatory disorders including osteoarthritis.

Item Type:	Article
Authors/Creators:	Ding, C and Cicuttini, F
Journal or Publication Title:	IDrugs
ISSN:	1369-7056
Item Statistics:	View statistics for this item

Actions (login required)

Item Control Page